Skip to main
SINT

SINT Stock Forecast & Price Target

SINT Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SINTX Technologies is positioned for long-term growth as a leader in the development and manufacturing of silicon nitride biomaterials for medical devices and other high-value applications. Their strategic focus on higher-margin opportunities, expansion into new markets, and partnerships with larger industry players make them an attractive investment opportunity. With a strong intellectual property portfolio and a proven track record of safety and effectiveness, SINTX is primed for success in the billion-dollar medical device market.

Bears say

SINTX Technologies is well-positioned for success in the orthopedic implant market with strong leadership, partnerships, and clinical advancements; yet, challenges such as adoption by surgeons and hospitals, competition from cheaper alternatives, and potential patent risks may inhibit its growth and market share. However, the company's diversification into other applications such as wound care, surgical textiles, and antimicrobial materials could provide long-term growth opportunities. Investors should closely monitor the company's sales and revenue growth as well as its ability to maintain and secure new patents.

SINT has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SINTX Technologies Inc (SINT) Forecast

Analysts have given SINT a Strong Buy based on their latest research and market trends.

According to 2 analysts, SINT has a Strong Buy consensus rating as of Apr 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SINTX Technologies Inc (SINT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.